UNSPSC 51282937: Sitafloxacin

This classification denotes a quinolone antibiotic with the molecular formula C19H18ClF2N3O3, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier 3GJC60U4Q8, chemically known as 7-((7s)-amino-5-azaspiro(2,4)heptan-5-yl)-8-chloro-6-fluoro-1-((1r,2r)-cis-2-fluoro-1-cyclopropyl)-1,4-dihydro-4-oxoquinolone-3-carboxylic acid but generally known as sitafloxacin, which bears US NIH Compound Identifier 73011.

UNSPSC 51282937 Sitafloxacin, a Commodity code, shows minimal relevant state and local procurement activity aligned to its nominal scope. The recent opportunities posted under this code focus instead on naloxone and drug deactivation systems, direct-to-manufacturer pharmacy programs, emergency medical supplies for fire rescue operations, and generic multi-source pharmaceuticals and over-the-counter products — none of which are sitafloxacin-specific fluoroquinolone antibiotics. State and local buyers are sourcing broad pharmacy benefit products, emergency medical consumables, and pharmaceutical contracting platforms rather than individual antibiotic pharmaceuticals by name. The code appears to reflect a taxonomy mismatch between the Commodity designation and actual procurement practice in state and local health systems, where pharmaceutical acquisitions typically occur through multi-product RFPs, cooperative purchasing agreements, or direct-to-wholesaler arrangements rather than single-drug solicitations.

Recent activity spans Florida, Texas, and Minnesota through diverse issuing bodies. Seminole County, Florida issued an IFB (IFB60459723LAS, due July 26, 2023) for naloxone and drug deactivation systems with annual quantities and quarterly delivery requirements. The Texas Health and Human Services Commission posted an RFI (HHS0017013, due April 3, 2026) exploring direct-to-manufacturer prescription programs and vendor capacity for negotiated pharmacy benefit contracting. The City of Tampa issued an IFB (26P00145, due March 13, 2026) for 169 line items of medical and first aid supplies supporting the Tampa Fire Department Rescue Division, with an estimated contract value of $700,000 and a 5 percent bid discount designated for certified Small Local Business Enterprises. The Minnesota Multistate Cooperative Purchasing Alliance (MMCAP) released an RFP (S1070000015802, due March 26, 2026) for generic multi-source pharmaceuticals and OTC products distributed across state and local facilities in Minnesota and Oregon, with evaluations weighted 75 percent on price competitiveness. Vendors pursuing pharmaceutical categories at the state and local level should expect cooperative purchasing frameworks, authorized-wholesaler mandates, cGMP and DSCSA compliance requirements, and multi-year contract structures rather than single-agent or single-jurisdiction buying patterns.